v3.26.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Restatement of Financial Statements

As a result of the restatement, the Company prepared the following table to illustrate the effect on the financial statements for the year ended March 31, 2024.

 

   As Reported   As Revised     
   March 31, 2024   March 31, 2024   Difference 
Liabilities               
Accrued expenses  $2,130   $2,789   $(659)
                
Total equity attributable to ZRCN Inc. stockholders               
Retained earnings  $7,421   $6,762   $659 

 

As a result of the restatement, the Company prepared the following table to illustrate the effect on the financial statements for the three months ended June 30, 2024.

 

   As Reported   As Revised     
   September 30, 2024  

September 30, 2024

   Difference 
Liabilities               
Accrued expenses  $2,246   $2,660   $(414)
                
Total equity attributable to ZRCN Inc. stockholders               
Retained earnings  $5,530   $5,116   $(414)
Schedule of Accounts Receivable

Accounts receivable consisted of the following:

 

(In thousands)  September 30, 2025   March 31, 2025 
Accounts receivable  $11,113  $6,155 
Less provision for credit losses   (63)   (53)
Accounts receivable, net  $11,050   $6,102 
Schedule of Provision for Credit losses

Activity related to the Company’s provision for credit losses was as follows:

 

(In thousands)  September 30, 2025   March 31, 2025 
Balance, beginning of period  $53   $14 
Credit loss (recovery) provision   10    195 
Write-offs       (156)
Balance, end of period  $63   $53 
Schedule of Dilutive Securities Outstanding

 

   For the Six Months Ended September 30, 
   2025   2024 
Stock options   3,216,500    298,000 
Warrants   217,184    217,184 

 

   For the Three Months Ended September 30, 
   2025   2024 
Stock options   3,216,500    198,000 
Warrants   217,184    217,184